Madison L. Chimenti

Emergency Medicine

1120 15th St
Augusta, GA 30912

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia.

Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 08, 2023

MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.

MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.

Journal: Leukemia

Published: February 23, 2023

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.

Journal: Cancers

Published: October 24, 2022

Showing 1-3 of 3

Last Updated: 09/26/2026